BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information letter on Etopophos® 100-/1000 mg (etoposide): Shortage and procedure for ordering

Active substance: etoposide

The company Bristol-Myers Squibb GmbH & Co. KGaA is circulating information regarding the shortage of Etopophos® 100-/1000 mg.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 146KB, File is accessible

Use of cookies

Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)

OK